Catalyst Pharmaceuticals, Inc. (CPRX)
25.84
-0.35
(-1.34%)
USD |
NASDAQ |
Apr 15, 16:00
25.84
0.00 (0.00%)
After-Hours: 16:50
Catalyst Pharmaceuticals Research and Development Expense (Annual) : 12.71M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| ADMA Biologics, Inc. | 4.762M |
| ANI Pharmaceuticals, Inc. | 51.66M |
| Indivior Pharmaceuticals, Inc. | 80.00M |
| Inovio Pharmaceuticals, Inc. | 52.79M |
| United Therapeutics Corp. | 550.00M |